Crossmark

Ivosidenib: First Global Approval

Crossref DOI link: https://doi.org/10.1007/s40265-018-0978-3

Published Online: 2018-09-12

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dhillon, Sohita
License Information

Text and Data Mining valid from 2018-09-01
More Information

Article History

First Online: 12 September 2018

Change Date: 4 January 2019

Change Type: Correction

Change Details: IThe article Ivosidenib: First Global Approval, written by Sohita Dhillon, was originally published Online First without open access.

Compliance with Ethical Standards

:

: The preparation of this review was not supported by any external funding.

: During the peer review process the manufacturer of the agent under review was offered an opportunity to comment on the article. Changes resulting from any comments received were made by the authors on the basis of scientific completeness and accuracy. Sohita Dhillon is a salaried/ contracted employee of Adis/Springer, is responsible for the article content and declares no relevant conflicts of interest.